{
  "meta": {
    "title": "Cutaneous_Drug_Eruptions",
    "url": "https://brainandscalpel.vercel.app/cutaneous-drug-eruptions-faaeb46a.html",
    "scrapedAt": "2025-11-30T11:11:54.707Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Behcet's syndrome</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Herpes genitalis</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Fixed drug eruption</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Pemphigus vulgaris</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 27-year-old sexually active male presented with a solitary painful erosive lesion on the glans penis that appeared 6 hours after taking cotrimoxazole for fever. He reports developing a similar lesion at the same site a few months ago after taking the same medication. The current lesion healed with pigmentation. What is the most likely diagnosis?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025062823a2664b-6650-402a-afeb-5ee3c975cba0.png\"></span></p>",
      "unique_key": "DT1229755",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229755,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation for answer:</strong></p>\n<p>FDE typically presents as recurrent lesions at the same site following re-exposure to the same drug, healing with residual pigmentation.</p>\n<p><strong>Fixed drug eruption (FDE):</strong></p>\n<ul>\n<li>It is a type of drug-induced exanthem that characteristically recurs at the<strong> same site upon re-exposure</strong> to the offending drug.</li>\n<li>The pathogenesis involves type IV hypersensitivity and epidermal T-suppressor cytotoxic cells.</li>\n<li><strong>Time course:</strong> On first exposure, lesions typically appear within 7&ndash;10 days. On re-exposure, they can occur within 30 minutes to 8 hours.</li>\n<li>Common causative drugs: tetracyclines, NSAIDs, sulfonamides, and sedatives.</li>\n<li>It typically presents with well-circumscribed erythematous or bullous lesions that heal with slate-brown pigmentation due to pigmentary incontinence and dermal melanophages.</li>\n<li>The genitalia and perianal region are commonly involved.</li>\n<li>Hyperpigmentation is more prominent in individuals with darker skin tones.</li>\n</ul>\n<img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025062852c2d13f-5cc9-455a-8b6e-aa3c77c68b1a.png\" alt=\"\" />\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Behcet&rsquo;s syndrome (Option A):</strong> Presents with recurrent oral and genital aphthous ulcers and systemic vasculitis; no history of drug intake is required.</p>\n<img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202506289983e541-0410-4509-8b2c-5a25300ffa1d.png\" alt=\"\" />\n<p><strong>Herpes genitalis (Option B):</strong> Painful grouped vesicles with possible systemic symptoms; not associated with drug intake or residual pigmentation.</p>\n<img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202506284539e8e2-a7c9-4081-a635-741cfc0e2fbc.png\" alt=\"\" />\n<p><strong>Pemphigus vulgaris (Option D):</strong> Autoimmune blistering disorder involving mucosa and skin with flaccid bullae and erosions; usually more widespread and not drug-induced.<br><img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250628598fa24f-9876-4354-81cc-dd965e2cf331.png\" alt=\"\" /> <strong>Key Takeaways:</strong></p>\n<ul>\n<li>FDE presents as recurrent, well-demarcated lesions that heal with pigmentation on the same site.</li>\n<li>Genital lesions following drug intake are a hallmark of fixed drug eruption.&nbsp;</li>\n</ul>",
      "correct_choice_id": 3,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Psoriasis</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythema multiforme</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Fixed drug eruption</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">SJS</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A male aged 30 years presents a skin lesion over his body 1 week after taking NSAIDs. What appears to be the most probable diagnosis?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025070763e16c90-6ea7-48c5-8e2d-95c7c20ec6c7.png\"></span></p>",
      "unique_key": "DT1229760",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229760,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><br /> <strong>Explanation:</strong></p>\n<p>A solitary or localised skin lesion appearing after NSAID intake and recurring at the same site with drug re-exposure is typical of <strong>fixed drug eruption (FDE)</strong>, making it the most probable diagnosis.</p>\n<ul>\n<li>Fixed drug eruptions typically occur <strong>7&ndash;14 days after initial exposure</strong> to a drug such as NSAIDs.</li>\n<li>Lesions are <strong>well-demarcated</strong>, erythematous to violaceous, may become <strong>bullous or erosive</strong>, and always <strong>heal with slate-brown hyperpigmentation</strong>.</li>\n<li>Commonly affects the <strong>genitalia, lips, and perianal region</strong>.</li>\n<li><strong>Vesicles or bullae</strong> with <strong>central epidermal denudation</strong> may be seen.</li>\n<li>On resolution, lesions leave <strong>post-inflammatory hyperpigmentation</strong>.</li>\n<li><strong>Re-exposure</strong> to the offending drug causes <strong>recurrence at the same site</strong>, a hallmark feature.</li>\n<li>Common causative drugs include:\n<ul>\n<li>NSAIDs</li>\n<li>Sulfonamides</li>\n<li>Barbiturates</li>\n<li>Tetracyclines</li>\n<li>Carbamazepine</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Psoriasis (Option A):</strong> It is a chronic, immune-mediated skin disorder presenting as erythematous plaques with silvery scales, often on extensor surfaces. It is not typically drug-induced and doesn&rsquo;t recur at fixed locations.</p>\n<img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250628c16f34f1-a946-464c-a1aa-b6ac131e0f2b.png\">\n<p><strong>Erythema multiforme (Option B):</strong> It presents with target lesions, commonly on the distal extremities, and is frequently triggered by infections (especially HSV).</p>\n<img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250707a3972cc5-32e5-442e-bc94-8766ea2d7dd1.png\">\n<p><strong>Stevens&ndash;Johnson syndrome (Option D):</strong> It is a severe mucocutaneous reaction with systemic symptoms and epidermal detachment involving &lt;10% BSA. It&rsquo;s more acute, painful, and generalised compared to the localised nature of fixed drug eruptions.</p>\n<img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250628410e4d57-3ace-4b1b-8cde-418900798234.png\">\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Suspect <strong>fixed drug eruption</strong> when lesions recur at the <strong>same site</strong> upon drug re-exposure.</li>\n<li><strong>NSAIDs</strong> are among the most frequent culprits.</li>\n<li>Post-lesional <strong>hyperpigmentation</strong> helps confirm the diagnosis retrospectively.</li>\n</ul>",
      "correct_choice_id": 13,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Annular</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Discoid</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Iris</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Bullous</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the morphology of the lesion<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202506283ac373ac-bfbf-4a8e-bcef-cc45e6e1af3e.png\"></span></p>",
      "unique_key": "DT1229766",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229766,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The lesion shows concentric zones of colour change- red, white, and purple- typical of an <strong>iris lesion</strong>, which is the hallmark of erythema multiforme.</p>\n<ul>\n<li><strong>Iris lesions (target lesions)</strong> are characteristic of <strong>erythema multiforme (EM)</strong>.</li>\n<li>These lesions have a <strong>three-zone pattern</strong>:\n<ul>\n<li>Central dusky red/purpuric area</li>\n<li>Middle pale edematous ring</li>\n<li>Outer erythematous rim with well-defined edges</li>\n</ul>\n</li>\n<li>Lesions are <strong>round</strong>, typically <strong>&lt;3 cm</strong>, and may be <strong>flat or slightly raised maculopapules</strong>.</li>\n<li>Appear in <strong>successive crops</strong>, evolving over <strong>48 hours</strong> and resolving in <strong>1&ndash;2 weeks</strong> (sometimes up to 3 weeks).</li>\n<li>Frequently involves the <strong>dorsa of hands, palms, wrists, feet</strong>, and <strong>extensor limbs</strong>; the <strong>face is less commonly involved</strong>.</li>\n<li>Mucosal lesions may occur in the oral or genital areas.</li>\n<li>Common triggers include <strong>HSV infections</strong> and medications; recurrent HSV-associated EM can be prevented with <strong>antiviral prophylaxis</strong>.</li>\n<li>EM can occur at <strong>any age</strong>, including neonates and children.</li>\n<li>Lesions may occasionally form <strong>bullae</strong> or show <strong>photoaggravation</strong> (e.g., due to HSV or statins).</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Annular</strong> <strong>(Option A):</strong> It refers to a ring-like lesion, often seen in conditions like tinea or subacute cutaneous lupus. It lacks the three distinct zones of a target lesion.</p>\n<p><strong>Discoid (Option B):</strong> The lesions are coin-shaped plaques, typically used to describe lesions in discoid lupus erythematosus; they are homogeneous, not concentric.</p>\n<p><strong>Bullous (Option D):</strong> It refers to fluid-filled blisters &gt;0.5 cm, which are not the primary feature of EM iris lesions, though occasional bullae may form in some EM cases.</p>\n<p><strong>Key Notes:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250628f0099efa-d521-4db8-b804-1bce8a545f13.png\"><ul>\n<li>ANNULAR - Ring-like arrangement.</li>\n<li>ARCUATE - Half-moon or arc-shaped.</li>\n<li>CIRCINATE - Circular or ringlike in shape.</li>\n<li>COALESCING - Fusing of originally separate parts.</li>\n<li>CONFLUENT - Joining or running together.</li>\n</ul>\n<p><br /> <strong>Key Takeaways:</strong></p>\n<ul>\n<li>EM classically presents with <strong>iris/target lesions</strong>.</li>\n<li>Lesions have <strong>three concentric zones</strong>, and are <strong>&lt;3 cm</strong>, and usually affect <strong>acral sites</strong>.</li>\n<li>HSV is the main cause; <strong>antiviral suppression</strong> is helpful in recurrent cases.</li>\n</ul>",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Vesicle and bullae are not seen</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Associated with internal malignancy</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Target lesion with bull's eye lesion seen over palms and soles</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Associated with adverse reaction to drugs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All the following are TRUE about erythema multiform EXCEPT :</span></p>",
      "unique_key": "DT1229769",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229769,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Vesicles and bullae <strong>can be seen</strong> in erythema multiforme, especially in more severe forms; hence, this statement is false.</p>\n<ul>\n<li>Erythema multiforme (EM) is an acute, self-limited hypersensitivity reaction.</li>\n<li>Characterised by <strong>target (iris) lesions</strong>: 3 concentric zones &ndash; dusky centre, pale edematous ring, and peripheral erythema. (Option C)</li>\n<li>Lesions are commonly seen over the <strong>palms, soles, and extensor surfaces</strong>.</li>\n<li><strong>Vesicles and bullae</strong> may develop in the center of target lesions, especially in EM major.</li>\n<li>Most commonly associated with <strong>herpes simplex virus (HSV-1)</strong>; other triggers include Mycoplasma and drugs (e.g., sulfonamides, phenytoin). (Option D)</li>\n<li>Rarely, EM can be associated with <strong>internal malignancies</strong>. (Option B)</li>\n<li>Differentiated from SJS/TEN by less mucosal involvement and milder course.</li>\n</ul>\n<p>&nbsp;</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250628b7203f9c-be01-421e-9945-8221d6b13a5f.png\">\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202506284d838b87-b500-49e7-85ab-82bb3158607d.png\">",
      "correct_choice_id": 31,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Vaccination</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignancy</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Drugs</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Herpes infection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old male presents with multiple lesions on the palms, some of which exhibit concentric rings of purple, pallor, and red zones. He had an episode of cold sores a few days ago. What is the most common triggering factor for this condition?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250628cd116ed7-aba4-450d-9618-6d572640911f.png\"></span></p>",
      "unique_key": "DT1229778",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229778,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The presence of target lesions following a cold sore episode is characteristic of erythema multiforme, most commonly triggered by herpes simplex virus, especially type 1.</p>\n<ul>\n<li>EM is an acute, self-limiting, immune-mediated hypersensitivity reaction.</li>\n<li>Classic &ldquo;target lesions&rdquo;: concentric rings with dusky center, pale intermediate ring, and red outer zone.</li>\n<li>Most common trigger: Herpes simplex virus (HSV-1 &gt; HSV-2)&mdash;especially in EM minor and recurrent cases.</li>\n<li>Lesions predominantly on extensor surfaces, especially palms, soles, forearms, and sometimes the mucosa.</li>\n<li>Other infectious causes include Mycoplasma pneumoniae, adenovirus, CMV, EBV, and hepatitis B.</li>\n<li>Drug-induced EM (~10%): Common agents include sulfonamides, NSAIDs, and anticonvulsants.</li>\n<li>In up to 50% of cases, no trigger may be found.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Vaccination (Option A):</strong> Rare trigger for EM; most often seen in children or post-smallpox vaccination.</p>\n<p><strong>Malignancy (Option B):</strong> Rare cause; more often associated with paraneoplastic EM-like eruptions in hematologic cancers.</p>\n<p><strong>Drugs (Option C):</strong> Significant cause but still less common than HSV; drug-induced EM is more often severe or progresses to SJS/TEN.<br /> </p>",
      "correct_choice_id": 44,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Mucosal involvement always follows the skin eruption</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">The Nikolsky sign is specific for Stevens-Johnson syndrome</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">The eruption typically begins on the lower limbs and spares palms and soles</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">A prodromal phase with systemic symptoms usually precedes the rash</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 34-year-old man presents with a 3-day history of fever, malaise, and a sore throat. He developed painful red macules and atypical targetoid lesions on his face and upper torso, which have now spread to involve his limbs and soles. He also complains of painful oral ulcers and difficulty swallowing. On examination, there is periungual dusky erythema and a positive Nikolsky sign. He had started allopurinol 12 days ago. Which of the following statements regarding his condition is most accurate?</span></p>",
      "unique_key": "DT1229781",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229781,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation Of</strong> <strong>Answer:</strong></p>\n<p>The diagnosis is Stevens&ndash;Johnson syndrome (SJS), suggested by the prodrome of fever and malaise, painful mucocutaneous targetoid lesions with a positive Nikolsky sign, and recent allopurinol use. The most accurate statement is that a prodromal phase with systemic symptoms typically precedes the rash.</p>\n<ul>\n<li>Latent period after drug initiation: <strong>5&ndash;28 days</strong>, most often 7&ndash;10 days</li>\n<li>Prodrome: <strong>Malaise, fever, URTI symptoms</strong></li>\n<li>Skin lesions begin as <strong>atypical targets/purpuric macules</strong> on the <strong>face and chest</strong>, spreading rapidly</li>\n<li>Lesions may involve <strong>palms and soles</strong> and coalesce, forming <strong>blisters and flaccid bullae</strong></li>\n<li><strong>Nikolsky sign</strong> is often positive but <strong>not specific</strong></li>\n<li><strong>Mucosal involvement</strong> (oral, ocular, genital, respiratory, GI) may occur <strong>before, after, or with</strong> cutaneous lesions</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250628cadb7c71-eb3c-4ff6-9ee1-e0d1e3ac73c2.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Mucosal involvement always follows the skin eruption (Option</strong> <strong>A):</strong> Mucosal involvement can <strong>precede, follow, or occur simultaneously</strong> with the skin rash</p>\n<p><strong>The Nikolsky sign is specific for Stevens&ndash;Johnson syndrome (Option B):</strong> Nikolsky sign is <strong>not specific</strong>; also seen in pemphigus and other bullous diseases</p>\n<p><strong>The eruption typically begins on the lower limbs and spares palms and soles (Option C):</strong> The eruption typically <strong>starts on the face and chest</strong>, not lower limbs; <strong>palms and soles</strong> are often involved</p>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Viral infection</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Drug induced</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Bacterial infection</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Idiopathic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24-year-old patient, recently started on antiepileptic medication, presents with dusky erythematous rashes over the body along with erosions of the lips and other mucosal surfaces for the past 2 days. There is epidermal detachment noted over multiple sites. What is the most likely triggering factor for this presentation?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202506284b27718e-9ddc-4d20-b273-cc090a5e466a.png\"></span></p>",
      "unique_key": "DT1229784",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229784,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>SJS/TEN typically presents with acute mucocutaneous erosions and is most commonly drug-induced, especially following exposure to high-risk medications within the past 1&ndash;3 weeks.</p>\n<ul>\n<li>Toxic epidermal necrolysis (TEN) is a potentially life-threatening dermatologic disorder characterised by widespread (&gt; 30% BSA) erythema, necrosis, and bullous detachment of the epidermis and mucous membranes, resulting in exfoliation.</li>\n<li>Mucous membrane involvement can result in gastrointestinal haemorrhage, respiratory failure, ocular abnormalities, and genitourinary complications.</li>\n<li>TEN is most commonly drug-induced:-\n<ul>\n<li>antibiotics (sulfonamides)</li>\n<li>antiepileptic drugs (Phenobarbital, Phenytoin)</li>\n<li>nonsteroidal anti-inflammatory drugs (NSAIDs)</li>\n<li>ampicillin</li>\n<li>allopurinol</li>\n<li>antiretroviral drugs (nevirapine, abacavir).</li>\n</ul>\n</li>\n<li>Treatment of SJS/TEN begins with immediate withdrawal of the culprit drug and supportive care in an intensive care or burn unit.\n<ul>\n<li>First-line measures include wound care, nutrition, analgesia, and infection prevention.</li>\n<li>Second-line therapies include intravenous immunoglobulin (IVIG), corticosteroids (e.g., IV methylprednisolone or oral prednisolone), and ciclosporin.</li>\n<li>Treatment choice depends on severity, timing, and center experience.</li>\n</ul>\n</li>\n</ul>\n<h3>Explanation of Other Options:</h3>\n<p><strong>Viral infection (Option A):</strong> Can cause erythema multiforme, but is not a typical trigger for TEN.</p>\n<p><strong>Bacterial infection (Option C):</strong> Rarely causes TEN. More often, bacterial sepsis is a <em>complication</em> of TEN.</p>\n<p><strong>Idiopathic (Option D):</strong> While a small proportion of SJS/TEN cases are idiopathic, drugs are by far the most common cause.</p>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">HLA B1502</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">HLA B5801</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">HLA DQ2/ DR3/ DR4</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">HLA DR4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old man with multiple episodes of generalised tonic-clonic seizures was started on phenytoin. Seven days later, he presents with mucosal erosions, hemorrhagic crusting of the lips, and multiple targetoid lesions on the trunk. Which of the following genetic factors most strongly predisposes to this adverse reaction?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202506285941b477-693c-4a59-96e4-ce3ea13d09f0.png\"></span></p>",
      "unique_key": "DT1229788",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229788,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>HLA-B*1502 is strongly associated with phenytoin-induced Stevens&ndash;Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN), particularly in Asian populations.</p>\n<ul>\n<li>SJS/TEN is a severe mucocutaneous reaction characterised by widespread epidermal necrosis and mucosal involvement, most often drug-induced (~85% of cases).</li>\n<li>Phenytoin is a high-risk drug known to cause SJS/TEN, especially in genetically predisposed individuals.</li>\n<li>MHC class I-restricted presentation of drugs leads to CD8<sup>+</sup> cytotoxic T lymphocyte activation and keratinocyte apoptosis, largely mediated by granulysin.</li>\n<li><strong>HLA-B1502</strong>, prevalent in Southeast Asian populations, is a key genetic marker predisposing to SJS/TEN induced by aromatic anticonvulsants like phenytoin and carbamazepine.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>HLA-B5801 (Option B):</strong> Associated with allopurinol-induced SJS/TEN, not phenytoin.</p>\n<p><strong>HLA-DQ2/DR3/DR4 (Option C):</strong> Associated with autoimmune conditions, not SJS/TEN.</p>\n<p><strong>HLA-DR4 (Option D):</strong> Linked with rheumatoid arthritis, not drug-induced SCARs.</p>\n<p><strong>Key Takeaway:</strong><br /> </p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202506281aaf1328-a6de-42cd-b496-d44ac3f003f4.png\">",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythema multiforme</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Lichen planus</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Fixed drug eruption</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Eczema</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Interface dermatitis is seen in all of the following conditions except :</span></p>",
      "unique_key": "DT1229791",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229791,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Eczema does not typically exhibit interface dermatitis; instead, it shows spongiosis, whereas the other options are classic examples of interface dermatitis.</p>\n<p><strong>Interface dermatitis</strong> refers to a histopathologic pattern involving damage at the dermo-epidermal junction and basal keratinocyte apoptosis, commonly mediated by T-cells.</p>\n<ul>\n<li>It includes both <strong>vacuolar</strong> and <strong>lichenoid</strong> patterns:\n<ul>\n<li><em>Vacuolar</em>: Basal cell vacuolization with sparse dyskeratosis</li>\n<li><em>Lichenoid</em>: Dense band-like lymphocytic infiltrate with numerous apoptotic keratinocytes</li>\n</ul>\n</li>\n<li>Conditions showing interface dermatitis include:<br /> <strong>Lichen planus</strong> (lichenoid pattern)<br /> <strong>Erythema multiforme</strong> (vacuolar interface with dyskeratosis)<br /> <strong>Fixed drug eruption</strong> (interface changes with eosinophils)</li>\n<li>Healing interface dermatitis shows <strong>pigment-laden macrophages</strong> in the dermis.</li>\n<li>Interface changes may be seen in autoimmune (e.g., lupus), infectious (e.g., viral exanthems), and drug-induced skin lesions.</li>\n<li><strong>Histologic variants</strong> of interface dermatitis:\n<ul>\n<li><em>Non sensu strictu</em>: minimal basal vacuolation, no dyskeratosis</li>\n<li><em>Vacuolar</em>: basal vacuolization + scattered dyskeratosis</li>\n<li><em>Lichenoid</em>: dense subepidermal infiltrate + numerous dyskeratotic cells</li>\n</ul>\n</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250628a3f601c4-e655-423c-99c9-4c144a974e14.png\">\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Erythema multiforme (Option A)</strong>: Shows vacuolar interface dermatitis with single-cell necrosis.</p>\n<p><strong>Lichen planus (Option B)</strong>: Prototypical lichenoid interface dermatitis.</p>\n<p><strong>Fixed drug eruption (Option C)</strong>: Can show vacuolar interface dermatitis with eosinophils and pigment incontinence.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Interface dermatitis involves basal keratinocyte damage and dermo-epidermal inflammation.</li>\n<li>It is seen in several autoimmune, drug-induced, and viral skin diseases, but <strong>not</strong> in spongiotic conditions like eczema.</li>\n<li>Histological recognition of interface patterns aids in diagnosis and understanding pathogenesis.</li>\n</ul>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Stevens Johnson Syndrome</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Toxic Epidermal Necrolysis</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Staphylococcal scalded skin syndrome</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Pemphigus vulgaris</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old male was started on phenytoin 10 days ago. He now presents with a 3-day history of fever, malaise, painful oral ulcers, and diffuse skin tenderness. On examination, there is extensive skin peeling in sheets, generalised erythema, positive Nikolsky sign, and involvement of 35% of total body surface area (BSA). What is the most likely diagnosis and the BSA category?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250628b6a82dfc-7377-459d-b86e-1bbe01330ec5.png\"></span></p>",
      "unique_key": "DT1229799",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229799,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>This patient presents with classic features of <strong>Toxic Epidermal Necrolysis (TEN)</strong>, including:</p>\n<ul>\n<li>Recent high-risk drug intake (phenytoin),</li>\n<li>Constitutional symptoms (fever, malaise),</li>\n<li><strong>Extensive mucocutaneous involvement</strong>,</li>\n<li><strong>Positive Nikolsky sign</strong>,</li>\n<li>Skin detachment involving <strong>&gt;30% BSA</strong>.</li>\n</ul>\n<p>TEN lies at the severe end of the <strong>SJS/TEN spectrum</strong>, and is defined by <strong>epidermal detachment &gt;30%</strong>, with widespread purpuric macules or flat atypical targets.</p>\n<ul>\n<li><strong>Classification of severity:</strong>\n<ul>\n<li><strong>SJS:</strong> &lt;10% BSA detachment</li>\n<li><strong>SJS-TEN Overlap:</strong> 10&ndash;30%</li>\n<li><strong>TEN:</strong> &gt;30% BSA, with skin sloughing and systemic involvement</li>\n</ul>\n</li>\n<li>Hemorrhagic mucosal crusting, particularly on the lips and genitals, is a hallmark of severe forms</li>\n</ul>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenytoin</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Sildenafil</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">NSAID</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Tetracycline</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 18-year-old girl develops an erythematous vesicular lesion on the lips within hours after taking a drug. She now presents with hyperpigmentation as shown. The most common drug implicated is.<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025062897d58b90-168d-4d75-8e80-8b4747571ee3.png\"></span></p>",
      "unique_key": "DT1229801",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229801,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>NSAIDs are one of the most commonly implicated drugs in fixed drug eruptions (FDE), especially with recurrences at the same site and post-inflammatory hyperpigmentation.</p>\n<ul>\n<li>Fixed drug eruption is a common drug-induced skin reaction characterised by erythematous to bullous lesions that recur at the same site on re-exposure to the offending drug.</li>\n<li>Lesions typically heal with <strong>slate-brown pigmentation</strong> due to <strong>pigmentary incontinence and melanophages</strong> in the upper dermis.</li>\n<li>Commonly affected sites include the <strong>lips, genitalia, perianal region</strong>, and sometimes mucosal surfaces.</li>\n<li><strong>NSAIDs</strong>, <strong>tetracyclines</strong>, <strong>sulfonamides</strong>, and <strong>sedatives</strong> are frequent culprits.</li>\n<li>The reaction may be <strong>type IV hypersensitivity mediated</strong>, with a role of <strong>epidermal T-suppressor/cytotoxic cells</strong> and persistent <strong>ICAM-1 expression</strong> in lesional keratinocytes.</li>\n<li>Lesions often reappear within <strong>30 minutes to 8 hours</strong> of re-exposure and may increase in number or size with continued drug intake.</li>\n<li>Although rare, FDEs may also be triggered by <strong>foods or UV light</strong>.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Phenytoin (Option A):</strong> Antiepileptic drug; more commonly associated with generalised drug eruptions like DRESS or morbilliform rashes, though rarely implicated in FDE.</p>\n<p><strong>Sildenafil (Option B):</strong> Can cause FDE, but less commonly than NSAIDs.</p>\n<p><strong>Tetracycline (Option D):</strong> A common cause of FDE, but NSAIDs are more frequent overall.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>NSAIDs are a leading cause of fixed drug eruption.</li>\n<li>Lesions appear quickly after drug intake and recur at the same site.</li>\n<li>Slate-brown post-inflammatory pigmentation is characteristic.</li>\n</ul>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenytoin and carbamezapine are most common drugs</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Association with HHV 6/7 virus infection</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Steroids are not effective</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Atypical lymphocytes are seen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is false about DRESS syndrome ?</span></p>",
      "unique_key": "DT1229804",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229804,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Systemic corticosteroids are the mainstay of treatment in Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), especially in moderate to severe cases. An oral dose of 1 mg/kg/day prednisolone is recommended, with tapering over 1&ndash;3 months. IV methylprednisolone is used when oral therapy is ineffective. Hence, Statement C is <strong>false.</strong></p>\n<ul>\n<li>DRESS syndrome is a severe drug-induced reaction involving fever, rash, lymphadenopathy, eosinophilia, and internal organ involvement.</li>\n<li><strong>Pathogenesis:</strong> Involves drug-specific T-cell reactions and viral reactivation (HHV-6, HHV-7, EBV, CMV).</li>\n<li><strong>Histology:</strong> Spongiosis, perivascular lymphocytic and eosinophilic infiltrates, and EM-like features may be present.</li>\n<li><strong>Common Drugs:</strong> Allopurinol, antiepileptics (phenytoin, carbamazepine, lamotrigine), sulpha drugs, antibiotics, NSAIDs, omeprazole.</li>\n<li>Atypical lymphocytes and eosinophilia are frequent lab findings.</li>\n<li>HHV-6 reactivation may correlate with disease severity and chronicity.</li>\n<li>Viral reactivation follows a sequence: HHV-6/EBV - HHV-7 - CMV.</li>\n<li><strong>Treatment:</strong>\n<ul>\n<li>First line: Systemic corticosteroids (oral/IV)</li>\n<li>Second line: Ciclosporin, IVIg</li>\n<li>Third line: Plasmapheresis, ECMO, cyclophosphamide, rituximab, valganciclovir, N-acetylcysteine</li>\n</ul>\n</li>\n</ul>\n<ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025062858c3f36c-3531-4216-88c5-df83df8e5ade.png\">\n<li>Atypical lymphocytes and eosinophilia are frequent lab findings.</li>\n<li>HHV-6 reactivation may correlate with disease severity and chronicity.</li>\n<li>Viral reactivation follows a sequence: HHV-6/EBV - HHV-7 - CMV.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Phenytoin and carbamazepine are the most common drugs</strong> <strong>(Option A)</strong>: Phenytoin and carbamazepine are well-known triggers of DRESS.</p>\n<p><strong>Association with HHV 6/7 virus infection (Option B)</strong>: Reactivation of HHV-6 and HHV-7 is commonly implicated.</p>\n<p><strong>Atypical lymphocytes are seen (Option D)</strong>: Atypical lymphocytes are commonly seen in blood films in DRESS.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>DRESS is a multisystem, potentially life-threatening drug reaction.</li>\n<li>Treatment requires systemic corticosteroids in most cases.</li>\n<li>Viral reactivation (especially HHV-6) is a key feature of its pathogenesis.</li>\n<li>Misconceptions about steroid inefficacy must be corrected.</li>\n</ul>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Lichen planus pigmentosus</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Fixed drug eruption</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Minocycline induced pigmentation</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Clofazimine induced pigmentation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 20-year-old male is on some long-term medication for his facial lesions. He starts developing pigmentation as shown in the image. The likely reason would be:<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025062838ad1646-1304-4a8b-b084-a8002d281d0b.png\"></span></p>",
      "unique_key": "DT1229809",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229809,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Minocycline, a second-generation tetracycline, can cause blue-black pigmentation, especially in areas of prior inflammation such as acne scars.</p>\n<ul>\n<li><strong>Cyclines</strong> (tetracycline group antibiotics) are the drugs of choice for acne.</li>\n<li><strong>Minocycline</strong> is associated with pigmentation due to deposition of iron-chelated drug in the skin.</li>\n<li>Pigmentation typically occurs in <strong>scars, sun-exposed areas, or diffusely</strong>, and may be permanent.</li>\n<li>Due to side effects like pigmentation, <strong>doxycycline and lymecycline</strong> are preferred over minocycline.</li>\n<li><strong>Sarecycline</strong>, a newer tetracycline derivative, is less likely to cause pigmentation or antibiotic resistance.</li>\n<li>Contraindicated in pregnancy and children under 8 years due to effects on bone and teeth.</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Lichen planus pigmentosus (Option A):</strong> Causes diffuse brown-gray pigmentation, not limited to acne scars.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025062848cd3593-b7c5-4205-9216-138091309d90.png\">\n<p><strong>Fixed drug eruption (Option B):</strong> Recurs at the same site with each exposure, usually well-demarcated, violaceous to brown macules or plaques.</p>\n<p><strong>Clofazimine pigmentation (Option D):</strong> Causes reddish-brown to black discolouration over sun-exposed and scarred areas with long-term use, often associated with leprosy treatment. The pigmentation may take months to fade even after stopping the drug.</p><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250628a75ed36f-fa28-4fc9-8a25-c51e9bc1f602.png\">\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Minocycline can lead to <strong>blue-black pigmentation in acne scars</strong>, especially with long-term use.</li>\n<li><strong>Doxycycline and lymecycline</strong> are preferred alternatives due to fewer pigmentary side effects.</li>\n</ul>",
      "correct_choice_id": 123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclophosphamide</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Bleomycin</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluticasone</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Docetaxel</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient on chemotherapy presents with the following lesions on the body. Which of the following drugs might have caused it ?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250628079dcb12-4f10-4e34-ad78-1f510867e827.png\"></span></p>",
      "unique_key": "DT1229811",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229811,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Bleomycin is classically associated with <strong>flagellate hyperpigmentation</strong>, a unique form of linear pigmentation caused by the accumulation of the drug in skin following minor trauma and scratching.</p>\n<ul>\n<li>Characteristic <strong>criss-cross pattern</strong> resembling whip marks</li>\n<li>Lesions begin as erythematous streaks, followed by <strong>hyperpigmentation</strong></li>\n<li>Caused by low levels of <strong>bleomycin-inactivating cysteine proteinase</strong> in skin</li>\n<li><strong>Bleomycin-induced pulmonary fibrosis</strong> occurs due to <strong>low levels of bleomycin-inactivating cysteine hydrolase in lung tissue</strong>, making the lungs particularly susceptible to drug toxicity, in addition to skin effects.</li>\n<li>Seen in up to <strong>8&ndash;22% of patients</strong> on bleomycin</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025062831c3833d-a7cc-48a9-b8fd-afb94ea81a51.png\">\n<ul>\n<li>Other agents like <strong>5-FU, vinorelbine, and daunorubicin</strong> may cause <strong>serpentine supravenous hyperpigmentation</strong> but not flagellate patterns</li>\n<li>Hyperpigmentation may affect <strong>nails, mucosa, and teeth</strong></li>\n<li>It may be <strong>reversible</strong> after stopping the drug</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Cyclophosphamide (Option A):</strong> Alkylating agent known for generalised or mucosal hyperpigmentation without the characteristic linear streaks</p>\n<p><strong>Fluticasone (Option C):</strong> A topical corticosteroid used in inflammatory dermatoses and respiratory conditions; does not cause hyperpigmentation</p>\n<p><strong>Docetaxel (Option D):</strong> Docetaxel is a taxane chemotherapeutic agent commonly associated with nail changes and alopecia, but not pigmentary disorders</p>\n<p><strong>Key Takeaways: </strong></p>\n<ul>\n<li><strong>Flagellate hyperpigmentation</strong> is a hallmark of <strong>bleomycin toxicity</strong></li>\n<li>Always consider <strong>drug history and lesion morphology</strong> in chemotherapy patients presenting with pigment changes</li>\n<li>Management is supportive; pigmentation often resolves after discontinuation</li>\n</ul>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Ampicillin</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Salbutamol</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Fexofenadine</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Steroids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 9-year-old child presented with sore throat, cervical lymphadenopathy, fever, and fatigue. Heterophile antibody test was positive. He was started on an antibiotic, and 5 days later developed a widespread, pruritic, maculopapular rash over the trunk and limbs, sparing the face. Which of the following drugs is most likely responsible?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202506282c6992a9-7e4d-4e7f-b7b7-34fbd33c09b5.png\"></span></p>",
      "unique_key": "DT1229813",
      "question_audio": null,
      "question_video": null,
      "map_id": 1229813,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The child has classic signs of <em>infectious mononucleosis</em> (IM) due to Epstein-Barr virus (EBV)&mdash;fever, sore throat, fatigue, and cervical lymphadenopathy with a positive heterophile antibody test. In such patients, administration of <strong>ampicillin or amoxicillin</strong> often results in a <strong>non-allergic, morbilliform rash</strong> in over 90% of cases.</p>\n<ul>\n<li>Rash usually appears 7&ndash;10 days after starting the drug</li>\n<li>Often itchy and most marked on extensor surfaces and pressure areas</li>\n<li>Involves palms and soles, may last for days to weeks</li>\n<li>May be accompanied by arthralgia or GI symptoms.</li>\n<li>The rash is a benign, non-allergic phenomenon</li>\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250628c3a7c548-37c8-417d-b28b-1d2ceace95bb.png\">\n<ul>\n<li>Associated classically with Epstein&ndash;Barr virus (EBV) infection</li>\n<li>Rash does not imply a true drug allergy&mdash;ampicillin can be used again later</li>\n<li>Other antibiotics like penicillin, tetracyclines, and azithromycin may occasionally cause similar reactions</li>\n<li>Periorbital oedema and palatal petechiae are other helpful diagnostic clues in mononucleosis</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Salbutamol (Option B):</strong> Not associated with cutaneous drug eruptions in mononucleosis. A &beta;2-agonist used in asthma; skin rashes are not a common adverse effect</p>\n<p><strong>Fexofenadine (Option C):</strong> Antihistamine, not known to cause rashes. Used to treat urticaria and allergic rhinitis.</p>\n<p><strong>Steroids (Option D):</strong> May help reduce inflammation and are sometimes used in severe EBV pharyngitis. Not implicated in the causation of drug-induced rash in mononucleosis.</p>",
      "correct_choice_id": 141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}